5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cells

Triple negative breast cancer: adjuvant chemotherapy effect on survival

(2011) L Steponaviciene et al.   Advances in Medical Sciences

Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell line

(2011) Gobind Singh et al.   BMC CANCER

Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: A pooled subset analysis of two phase III studies

(2011) Jacek Jassem et al.   BREAST

The Paradox of Triple Negative Breast Cancer: Novel Approaches to Treatment

(2011) Monica Fornier et al.   Breast Journal

MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer

(2011) Jelena Radojicic et al.   CELL CYCLE

Ixabepilone: Clinical Role in Metastatic Breast Cancer

(2011) Neelima Denduluri et al.   Clinical Breast Cancer

Metastatic Triple-negative Breast Cancer

(2011) E.A. Rakha et al.   CLINICAL ONCOLOGY

Clinicopathological features of triple-negative breast cancer in Taiwanese women

(2011) Kuo Yao-Lung et al.   International Journal of Clinical Oncology

Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer

(2011) Jiannan Wu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNA-mediated breast cancer metastasis: from primary site to distant organs

(2011) L Wang et al.   ONCOGENE

Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer

(2011) Françoise Rothé et al.   PLoS One

MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer

(2011) Cathy A. Andorfer et al.   TRENDS IN MOLECULAR MEDICINE

Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy

(2011) Hiroshi Yagata et al.   Breast Cancer

MicroRNA-mediated drug resistance in breast cancer

(2011) Kristy R. Kutanzi et al.   Clinical Epigenetics

microRNA, Cell Cycle, and Human Breast Cancer

(2010) Zuoren Yu et al.   AMERICAN JOURNAL OF PATHOLOGY

Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer

(2010) Edith A. Perez et al.   BREAST CANCER RESEARCH AND TREATMENT

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

(2010) Henri Roché et al.   BREAST CANCER RESEARCH AND TREATMENT

Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment

(2010) Jiayu Wang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Ixabepilone Plus Capecitabine for Breast Cancer Patients With an Early Metastatic Relapse After Adjuvant Chemotherapy: Two Clinical Trials

(2010) Monica Fornier   Clinical Breast Cancer

Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer

(2010) Lun Li et al.   Future Oncology

Characteristics of triple-negative breast cancer

(2010) Tim C. de Ruijter et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

5-fluorouracil drug alters the microrna expression profiles in MCF-7 breast cancer cells

(2010) Maitri Y. Shah et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

(2010) Joseph A. Sparano et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression

(2010) Bao Song et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Synergistic activity of ixabepilone plus other anticancer agents: preclinical and clinical evidence

(2010) Francis Lee et al.   Therapeutic Advances in Medical Oncology